Get the Stockscreener App
0.00
100.00%
-0.157
Glycomimetics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
See More
Previous Close:
$0.157
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.00M
Revenue:
$1.16M
Net Income/Loss:
$-39.74M
P/E Ratio:
0.00
EPS:
-0.62
Net Cash Flow:
$-35.02M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.63
Glycomimetics Inc Stock (GLYC) Company Profile
Name
Glycomimetics Inc
Sector
Industry
Phone
240-243-1201
Address
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Compare GLYC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLYC
Glycomimetics Inc
|
0.00 | 11.00M | 1.16M | -39.74M | -35.02M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.55 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.31 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.83 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
762.89 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.93 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-11-25 | Initiated | H.C. Wainwright | Buy |
| Jul-14-25 | Initiated | Wedbush | Outperform |
| Jun-25-25 | Initiated | Stifel | Buy |
| Mar-21-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-26-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-22-23 | Initiated | CapitalOne | Overweight |
| Nov-12-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-14-19 | Initiated | ROTH Capital | Buy |
| Aug-05-19 | Downgrade | Jefferies | Buy → Hold |
| Aug-05-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Apr-12-19 | Initiated | Piper Jaffray | Overweight |
| Dec-18-18 | Initiated | H.C. Wainwright | Buy |
| Jul-26-16 | Initiated | SunTrust | Buy |
| Mar-17-15 | Reiterated | Stifel | Buy |
View All
Glycomimetics Inc Stock (GLYC) Latest News
Combining machine learning predictions for GlycoMimetics Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser
Momentum divergence signals in GlycoMimetics Inc. chartJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Is GlycoMimetics Inc. stock bottoming out2025 Macro Impact & Fast Entry Momentum Alerts - Newser
Can technical indicators confirm GlycoMimetics Inc.’s reversalTrade Ideas & High Accuracy Swing Entry Alerts - Newser
will glycomimetics inc. bounce back from current support2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
Custom watchlist performance reports with GlycoMimetics Inc.Weekly Trend Report & Capital Efficiency Focused Strategies - Newser
Will GlycoMimetics Inc. bounce back from current support2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Real time scanner hits for GlycoMimetics Inc. explainedWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Has GlycoMimetics Inc. formed a bullish divergenceEarnings Trend Report & Real-Time Market Sentiment Alerts - Newser
How to manage a losing position in GlycoMimetics Inc.July 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
How institutional ownership impacts GlycoMimetics Inc. stockMarket Risk Report & Free Reliable Trade Execution Plans - Newser
Custom strategy builders for tracking GlycoMimetics Inc.Fed Meeting & Risk Controlled Stock Pick Alerts - Newser
What is GlycoMimetics Inc. s debt to equity ratio2025 Volatility Report & Growth Oriented Trade Recommendations - Lancaster City Council
How to monitor GlycoMimetics Inc. with trend dashboardsJuly 2025 Retail & Smart Allocation Stock Tips - Newser
What Fibonacci levels say about GlycoMimetics Inc. rebound2025 Fundamental Recap & AI Driven Stock Reports - Newser
Can GlycoMimetics Inc. recover in the next quarterJuly 2025 Fed Impact & High Conviction Investment Ideas - Newser
Will GlycoMimetics Inc. see short term momentumJuly 2025 Earnings & Fast Moving Stock Watchlists - Newser
How hedge fund analytics apply to GlycoMimetics Inc. stockMarket Rally & Growth Oriented Trade Recommendations - Newser
Trend analysis for GlycoMimetics Inc. this week2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Trendlines Converge — Decision Point for GlycoMimetics Inc.July 2025 Movers & Reliable Trade Execution Plans - beatles.ru
Sentiment Tools Show Shift in Trader Mood on GlycoMimetics Inc.July 2025 Closing Moves & AI Driven Stock Price Forecasts - beatles.ru
What data driven models say about GlycoMimetics Inc.’s future2025 Market Overview & Risk Managed Trade Strategies - Newser
Analyzing recovery setups for GlycoMimetics Inc. investorsJuly 2025 Reactions & Safe Capital Growth Tips - Newser
Reversal indicators forming on GlycoMimetics Inc. stockMarket Sentiment Report & Free Growth Oriented Trading Recommendations - Newser
Can GlycoMimetics Inc. deliver alphaStock Surge & Daily Chart Pattern Signals - beatles.ru
Real time breakdown of GlycoMimetics Inc. stock performanceAnalyst Downgrade & Entry and Exit Point Strategies - Newser
Multi asset correlation models including GlycoMimetics Inc.2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - Newser
Exit strategy if you’re trapped in GlycoMimetics Inc.Quarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
What candlestick patterns are forming on GlycoMimetics Inc.Market Sentiment Review & Fast Gain Stock Trading Tips - Newser
Sentiment analysis tools applied to GlycoMimetics Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - Newser
GlycoMimetics Inc. stock volume spike explained2025 Sector Review & Proven Capital Preservation Methods - Newser
Will GlycoMimetics Inc. face regulatory challenges2025 Market Sentiment & Weekly High Momentum Picks - خودرو بانک
Custom Dashboard Highlights GlycoMimetics Inc. Price MomentumJuly 2025 Market Mood & Stepwise Entry/Exit Trade Alerts - beatles.ru
Risk adjusted return profile for GlycoMimetics Inc. analyzedBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Glycomimetics Inc Stock (GLYC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):